Evotec SE and the service group Sartorius AG are taking a controlling stake in a new German company, Curexsys GmbH, in order to support the emerging science of therapeutic exosomes. Exosomes are small vesicles that transfer proteins and nucleic acids from one cell to another. Researchers have shown that exosomes can be engineered to contain drugs, something that is being exploited by a growing number of biotech companies.
